Folate-based systems currently represent the most advanced and extensively studied class, often achieving remarkably high tumor uptake values, sometimes exceeding 17% ID/g, though they are frequently challenged by significant renal accumulation, an issue that has been creatively mitigated through the use of albumin-binding entities and PEG linkers. The gene discussed is ALB; the disease is neoplasm.